Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
339
datasets available to search
ShareScore release 0.9.0
Dataset results
339 results for “CML”
TKI Discontinuation in CML Patients of China
ClinicalTrials.gov study NCT03251352. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax After TKI to Target Persisting Stem Cells in CML
ClinicalTrials.gov study NCT05701215. IPD Sharing: NO. Countries: 1. Publications: 0.
AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year
ClinicalTrials.gov study NCT00146913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)
ClinicalTrials.gov study NCT00171899. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib
ClinicalTrials.gov study NCT01223898. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant
ClinicalTrials.gov study NCT00413270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rollover Study of BMS-354825 in Patients With CML and Ph+ALL
ClinicalTrials.gov study NCT01030718. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Efficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib
ClinicalTrials.gov study NCT01400074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System
ClinicalTrials.gov study NCT05753384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gene Expression Profiles in CML Non-responders
ClinicalTrials.gov study NCT04219111. IPD Sharing: NO. Countries: 1. Publications: 0.
Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS
ClinicalTrials.gov study NCT00053287. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure
ClinicalTrials.gov study NCT04677439. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population
ClinicalTrials.gov study NCT04626024. IPD Sharing: NO. Countries: 1. Publications: 0.
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
ClinicalTrials.gov study NCT03595917. IPD Sharing: NO. Countries: 1. Publications: 0.
CML Pediatric ITK Response According to Molecular Identification at Diagnosis
ClinicalTrials.gov study NCT05605379. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of a High-CML Diet on Absorption and Excretion Levels in Healthy Adults
ClinicalTrials.gov study NCT03208946. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients
ClinicalTrials.gov study NCT03205267. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
ClinicalTrials.gov study NCT00428909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension
ClinicalTrials.gov study NCT01279473. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients
ClinicalTrials.gov study NCT05433532. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.